Related Experiment Video
Updated: Jul 4, 2025
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Rational Design of a Potent Antimicrobial Peptide Based on the Active Region of a Gecko Cathelicidin
Ying Cai1, Xingyu Wang1, Tianyu Zhang1
1Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan 650031, China.
Abstract:
The emergence of multidrug-resistant (MDR) bacteria presents a significant challenge to public health, increasing the risk of infections that are resistant to current antibiotic treatment. Antimicrobial peptides (AMPs) offer a promising alternative to conventional antibiotics in the prevention of MDR bacterial infections. In the present study, we identified a novel cathelicidin AMP from Gekko japonicus, which exhibited broad-spectrum antibacterial activity against both Gram-negative and Gram-positive bacteria, with minimal inhibitory concentrations ranging from 2.34 to 4.69 μg/mL. To improve its potential therapeutic application, a series of peptides was synthesized based on the active region of the gecko-derived cathelicidin. The lead peptide (RH-16) showed an antimicrobial activity comparable to that of the parent peptide. Structural characterization revealed that RH-16 adopted an amphipathic α-helical conformation. Furthermore, RH-16 demonstrated neither hemolytic nor cytotoxic activity but effectively killed a wide range of clinically isolated, drug-resistant bacteria. The antimicrobial activity of RH-16 was attributed to the nonspecific targeting of bacterial membranes, leading to rapid bacterial membrane permeabilization and rupture. RH-16 also retained its antibacterial activity in plasma and exhibited mild toxicity in vivo. Notably, RH-16 offered robust protection against skin infection in a murine model. Therefore, this newly identified cathelicidin AMP may be a strong candidate for future pharmacological development targeting multidrug resistance. The use of a rational design approach for isolating the minimal antimicrobial unit may accelerate the transition of natural AMPs to clinically applicable antibacterial agents.
Insights
A novel antimicrobial peptide (AMP) from gecko venom shows broad-spectrum activity against drug-resistant bacteria. This peptide, RH-16, effectively treats infections with low toxicity, offering a promising alternative to antibiotics.
Area of Science:
- Biochemistry
- Microbiology
- Pharmacology
Background:
- Multidrug-resistant (MDR) bacteria pose a significant global health threat, necessitating novel therapeutic strategies.
- Antimicrobial peptides (AMPs) are emerging as potential alternatives to conventional antibiotics due to their broad-spectrum activity and unique mechanisms of action.
Purpose of the Study:
- To identify and characterize a novel cathelicidin antimicrobial peptide (AMP) from *Gekko japonicus* with potential therapeutic applications against multidrug-resistant bacteria.
- To synthesize and evaluate a modified peptide (RH-16) derived from the natural AMP for enhanced efficacy and safety.
Main Methods:
- Isolation and identification of a novel cathelicidin AMP from *Gekko japonicus*.
- Synthesis and structural characterization of a derivative peptide (RH-16).
- Assessment of antibacterial activity, including minimal inhibitory concentrations (MICs), against Gram-negative and Gram-positive bacteria, as well as clinically isolated drug-resistant strains.
- Evaluation of hemolytic and cytotoxic activity, in vitro stability in plasma, and in vivo efficacy in a murine skin infection model.
Main Results:
- A novel cathelicidin AMP from *Gekko japonicus* demonstrated broad-spectrum antibacterial activity with MICs ranging from 2.34 to 4.69 μg/mL.
- The synthesized peptide RH-16 exhibited comparable antimicrobial activity to the parent peptide, adopted an amphipathic α-helical structure, and showed no hemolytic or cytotoxic effects.
- RH-16 effectively killed diverse drug-resistant bacteria, retained activity in plasma, displayed mild in vivo toxicity, and provided significant protection against skin infections in mice.
Conclusions:
- The gecko-derived cathelicidin AMP, particularly the rationally designed RH-16, represents a promising candidate for the development of new therapeutic agents against multidrug-resistant bacterial infections.
- The study highlights the potential of AMPs as a viable alternative to conventional antibiotics and emphasizes the utility of rational design in accelerating their clinical translation.
